MRE-269

Item number	Size	Delivery time	Price
TGM-T3S2007-5mg	5 mg	7 - 10 business days*	45.00€
TGM-T3S2007-1mL	1 ml	7 - 10 business days*	49.00€
TGM-T3S2007-10mg	10 mg	7 - 10 business days*	84.00€
TGM-T3S2007-25mg	25 mg	7 - 10 business days*	134.00€
TGM-T3S2007-50mg	50 mg	7 - 10 business days*	185.00€
TGM-T3S2007-100mg	100 mg	7 - 10 business days*	312.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor... more

Close menu

Product information "MRE-269"

Description: MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269(ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269(ACT-333679) is an active metabolite of Selexipag (S253150). Target: Prostaglandin Receptor. Smiles: N(CCCCOCC(O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3. References: Kuwano, K., et al.: J. Pharmacol. Exp. Ther., 322, 1181-1188 (2007)

Keywords:	MRE 269, MRE269, ACT-333679
Supplier:	TargetMol
Supplier-Nr:	T3S2007

Properties

MW:	419.52 D
Formula:	C25H29N3O3

Database Information

CAS :

475085-57-5| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "MRE-269"

Write a review